Group 1 - Tesla and LG Energy will jointly build a battery plant in Michigan with a total investment of $4.3 billion, and production is expected to start next year with an annual capacity of 50 GWh [1] - The batteries produced at this facility will be utilized in energy storage systems, specifically for Tesla's Megapack 3, rather than for electric vehicles [2] - The battery technology employed will be lithium iron phosphate, a sector largely dominated by Chinese manufacturers, with LG Energy being one of the few non-Chinese producers [2] Group 2 - LG Energy has previously indicated concerns regarding slowing demand for EV batteries due to U.S. tariffs and the phaseout of EV subsidies, which could negatively impact automakers and lead to increased vehicle prices [3][4] - The reduction in EV subsidies has already resulted in a significant decline in EV sales, with new registrations dropping by 41% in January, leading to a decrease in market share from 8.3% to 5.1% [5]

Core Viewpoint - The U.S. government has confirmed a $4.3 billion supply agreement between Tesla and LG Energy Solution to establish a lithium iron phosphate (LFP) battery cell manufacturing facility in Lansing, Michigan, with production expected to start in 2027 [1]. Group 1: Agreement Details - The agreement aims to create a robust domestic battery supply chain for Tesla's Megapack 3 energy storage systems produced in Houston [2]. - This deal is part of a broader initiative highlighted by the U.S. government to enhance energy security in the Indo-Pacific region [2]. Group 2: Market Context - LG Energy Solution is one of the few producers of LFP batteries in the U.S., a market segment that has been largely dominated by Chinese competitors [4]. - The deal is seen as a strategic move by Tesla to reduce its reliance on Chinese imports amid ongoing tariffs [3].

Core Viewpoint - Elevra Lithium has signed a non-binding memorandum of understanding with Mangrove Lithium for the supply of spodumene concentrate, potentially delivering up to 144,000 tonnes per annum starting in 2028, subject to market conditions [1][2]. Group 1: Agreement Details - The agreement could transition into a binding contract if Mangrove invests in a lithium conversion facility by June 2027 [2]. - The initial supply agreement is set to last five years, beginning in 2028 and increasing to 144,000 tonnes per annum by 2030, which would represent approximately 46% of anticipated sales [2]. Group 2: Mangrove's Operations - Mangrove plans to convert spodumene concentrate into battery-grade lithium hydroxide at its facility in eastern Canada, contributing to a domestic battery supply chain [3]. - The facility is designed to produce 20,000 tonnes per annum of battery-grade lithium, sufficient to power 500,000 electric vehicles [3]. Group 3: Technological Feasibility - Mangrove's pilot plant in Delta, Canada, has demonstrated the feasibility of its lithium conversion process, with test work on NAL spodumene expected to conclude by Q3 2026 [4]. - Mangrove has operationalized North America's first commercial electrochemical lithium refining plant with a capacity of 1,000 tonnes per annum [4]. Group 4: Strategic Fit and Financial Backing - Mangrove's partnership with Elevra is seen as a strategic fit to enhance supply chain security and create domestic jobs, aligning with Canada's Critical Minerals Strategy [5]. - Mangrove recently secured $85 million in funding, supporting its proprietary refining platform, which offers environmental and cost advantages [5][6]. Group 5: Expected Benefits - Expected benefits of the agreement include reduced logistics costs due to proximity, a pricing structure that ensures cash flow stability, and potential increased annual output from the NAL Brownfield Expansion [7].